Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study. [electronic resource]
Producer: 20190606Description: 176-186 p. digitalISSN:- 1873-2518
- Antibodies, Bacterial -- blood
- Bacterial Proteins -- genetics
- Carrier Proteins -- genetics
- Diphtheria-Tetanus-Pertussis Vaccine -- administration & dosage
- Female
- Haemophilus influenzae
- Hepatitis B Vaccines -- administration & dosage
- Humans
- Immunization, Secondary
- Immunogenicity, Vaccine
- Immunoglobulin D -- genetics
- Infant
- Lipoproteins -- genetics
- Male
- Pneumococcal Infections -- immunology
- Pneumococcal Vaccines -- adverse effects
- Poliovirus Vaccine, Inactivated -- administration & dosage
- Serogroup
- Streptococcus pneumoniae
- Vaccines, Combined -- administration & dosage
- Vaccines, Conjugate -- adverse effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.